Antibacterial Drugs Global Market by type, Scope, Analysis and Forecasts to 2019
ReportsWeb.com published “Antibacterial Drugs Global Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, April 08, 2017 ) Antibacterial drugs are chemical compounds used to treat infections caused by bacteria either by killing or inhibiting the growth of bacteria. The term antibiotic is often used synonymously with an antibacterial. However, antibiotics are agents that work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. The term antibiotic was originally coined to refer to any compound of microbial origin, which is antagonistic to the growth of the microbe. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. They can be bacteriostatic or bactericidal in nature, i.e., they either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad-spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).
For more information http://www.reportsweb.com/global-antibacterial-drugs-market-2015-2019
Publisher's analysts forecast the global antibacterial drugs market to grow at a CAGR of 1.06% over the period 2014-2019.
Covered in this report
In this report, Publisher covers the present scenario and growth prospects of the global antibacterial drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria. The various classes of antibacterial drug included in this report are beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, folate antagonists, tetracyclines, and other miscellaneous agents, which include glycopeptides, nitroimidazoles, lincosamides, lipopeptides, nicotinic acid derivatives, and polypeptide antibiotics.
Publisher's report, Global Antibacterial Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Allergan
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Teva Pharmaceuticals
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202010/sample
Other prominent vendors
- Abbott
- Achaogen
- Actelion
- AmpliPhi Biosciences
- Aspen Pharmacare
- Astellas
- AstraZeneca
- Aurobindo Pharma
- Baxter
- Basilea Pharmaceuticals
- Bayer
- Biocon
- Bristol-Myers Squibb
- Cempra
- Cipher Pharmaceuticals
- Corden Pharma
- Cornerstone Therapeutics
- Eli Lilly
- Exoxemis
- F. Hoffmann-La Roche
- Flynn Pharma
- Hospira
- Incepta Pharmaceuticals
- InSite Vision
- Insmed Incorporated
- Johnson & Johnson
- KaloBios Pharmaceuticals
- Kyorin Pharmaceutical
- Lupin Pharmaceuticals
- Lytix Biopharma
- Melinta Therapeutics
- Mylan
- Nektar
- Orchid Pharma
- Par Pharmaceutical
- Paratek Pharmaceuticals
- Pernix Therapeutics
- PTC Therapeutics
- RedHill Biopharma
- Sagent Pharmaceuticals
- Sanofi
- Shionogi
- Starpharma
- Sun Pharmaceutical
- Symbiomix
- Takeda Pharma
- Tetraphase Pharmaceuticals
- Theravance Biopharma
- The Medicines Company
- Valneva
- Wockhardt Global Solutions
Key market driver
- Special regulatory designations
- For a full, detailed list, view our report
Key market challenge
- Development of drug-resistant strains
- For a full, detailed list, view our report
Key market trend
- Strategic alliances and M&A
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202010/buying
For more information http://www.reportsweb.com/global-antibacterial-drugs-market-2015-2019
Publisher's analysts forecast the global antibacterial drugs market to grow at a CAGR of 1.06% over the period 2014-2019.
Covered in this report
In this report, Publisher covers the present scenario and growth prospects of the global antibacterial drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria. The various classes of antibacterial drug included in this report are beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, folate antagonists, tetracyclines, and other miscellaneous agents, which include glycopeptides, nitroimidazoles, lincosamides, lipopeptides, nicotinic acid derivatives, and polypeptide antibiotics.
Publisher's report, Global Antibacterial Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Allergan
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Teva Pharmaceuticals
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202010/sample
Other prominent vendors
- Abbott
- Achaogen
- Actelion
- AmpliPhi Biosciences
- Aspen Pharmacare
- Astellas
- AstraZeneca
- Aurobindo Pharma
- Baxter
- Basilea Pharmaceuticals
- Bayer
- Biocon
- Bristol-Myers Squibb
- Cempra
- Cipher Pharmaceuticals
- Corden Pharma
- Cornerstone Therapeutics
- Eli Lilly
- Exoxemis
- F. Hoffmann-La Roche
- Flynn Pharma
- Hospira
- Incepta Pharmaceuticals
- InSite Vision
- Insmed Incorporated
- Johnson & Johnson
- KaloBios Pharmaceuticals
- Kyorin Pharmaceutical
- Lupin Pharmaceuticals
- Lytix Biopharma
- Melinta Therapeutics
- Mylan
- Nektar
- Orchid Pharma
- Par Pharmaceutical
- Paratek Pharmaceuticals
- Pernix Therapeutics
- PTC Therapeutics
- RedHill Biopharma
- Sagent Pharmaceuticals
- Sanofi
- Shionogi
- Starpharma
- Sun Pharmaceutical
- Symbiomix
- Takeda Pharma
- Tetraphase Pharmaceuticals
- Theravance Biopharma
- The Medicines Company
- Valneva
- Wockhardt Global Solutions
Key market driver
- Special regulatory designations
- For a full, detailed list, view our report
Key market challenge
- Development of drug-resistant strains
- For a full, detailed list, view our report
Key market trend
- Strategic alliances and M&A
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202010/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results